Forte Biosciences (FBRX) Reports Q3 Loss of $0.26

Forte Biosciences (NASDAQ: FBRX) reported Q3 EPS of ($0.26).

For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c